Common Stock, Shares, Outstanding of Sonoma Pharmaceuticals, Inc. from 31 Mar 2011 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Sonoma Pharmaceuticals, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Mar 2011 to 31 Dec 2025.
  • Sonoma Pharmaceuticals, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 1,730,613, a 7.1% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Sonoma Pharmaceuticals, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 1,730,613 +114,848 +7.1% 31 Dec 2025 10-Q 10 Feb 2026 2026 Q3
Q3 2025 1,649,765 +311,150 +23% 30 Sep 2025 10-Q 04 Nov 2025 2026 Q2
Q2 2025 1,642,765 -17,361,628 -91% 30 Jun 2025 10-Q 07 Aug 2025 2026 Q1
Q1 2025 1,634,265 +853,894 +109% 31 Mar 2025 10-Q 10 Feb 2026 2026 Q3
Q4 2024 1,615,765 -12,068,568 -88% 31 Dec 2024 10-Q 05 Feb 2025 2025 Q3
Q3 2024 1,338,615 -3,840,718 -74% 30 Sep 2024 10-Q 07 Nov 2024 2025 Q2
Q2 2024 19,004,393 +13,862,797 +270% 30 Jun 2024 10-Q 08 Aug 2024 2025 Q1
Q1 2024 780,371 -4,153,179 -84% 31 Mar 2024 10-K 17 Jun 2025 2025 FY
Q4 2023 13,684,333 +10,574,681 +340% 31 Dec 2023 10-Q 08 Feb 2024 2024 Q3
Q3 2023 5,179,333 +2,076,361 +67% 30 Sep 2023 10-Q 13 Nov 2023 2024 Q2
Q2 2023 5,141,596 +2,040,659 +66% 30 Jun 2023 10-Q 10 Aug 2023 2024 Q1
Q1 2023 4,933,550 +1,832,613 +59% 31 Mar 2023 10-K 17 Jun 2024 2024 FY
Q4 2022 3,109,652 +1,016,743 +49% 31 Dec 2022 10-Q 14 Feb 2023 2023 Q3
Q3 2022 3,102,972 +98,231 +3.3% 30 Sep 2022 10-Q 14 Nov 2022 2023 Q2
Q2 2022 3,100,937 +1,008,028 +48% 30 Jun 2022 10-Q 11 Aug 2022 2023 Q1
Q1 2022 3,100,937 +1,008,028 +48% 31 Mar 2022 10-K 21 Jun 2023 2023 FY
Q4 2021 2,092,909 +13,850 +0.67% 31 Dec 2021 10-Q 11 Feb 2022 2022 Q3
Q3 2021 3,004,741 +963,332 +47% 30 Sep 2021 10-Q 15 Nov 2021 2022 Q2
Q2 2021 2,092,909 +125,951 +6.4% 30 Jun 2021 10-Q 16 Aug 2021 2022 Q1
Q1 2021 2,092,909 +315,426 +18% 31 Mar 2021 10-K 13 Jul 2022 2022 FY
Q4 2020 2,079,059 +301,576 +17% 31 Dec 2020 10-Q 16 Feb 2021 2021 Q3
Q3 2020 2,041,409 +723,405 +55% 30 Sep 2020 10-Q 20 Nov 2020 2021 Q2
Q2 2020 1,966,958 +649,788 +49% 30 Jun 2020 10-Q/A 17 Nov 2020 2021 Q1
Q1 2020 1,777,483 +461,148 +35% 31 Mar 2020 10-K 14 Jul 2021 2021 FY
Q4 2019 1,777,483 -10,194,845 -85% 31 Dec 2019 10-Q 14 Feb 2020 2020 Q3
Q3 2019 1,318,004 -5,161,629 -80% 30 Sep 2019 10-Q 14 Nov 2019 2020 Q2
Q2 2019 1,317,170 -5,115,579 -80% 30 Jun 2019 10-Q 13 Aug 2019 2020 Q1
Q1 2019 1,316,335 +630,588 +92% 31 Mar 2019 10-K 10 Jul 2020 2020 FY
Q4 2018 11,972,328 +7,334,787 +158% 31 Dec 2018 10-Q 14 Feb 2019 2019 Q3
Q3 2018 6,479,633 +2,155,802 +50% 30 Sep 2018 10-Q 08 Nov 2018 2019 Q2
Q2 2018 6,432,749 +2,125,687 +49% 30 Jun 2018 10-Q 08 Aug 2018 2019 Q1
Q1 2018 685,747 -3,603,575 -84% 31 Mar 2018 10-K 01 Jul 2019 2019 FY
Q4 2017 4,637,541 +379,787 +8.9% 31 Dec 2017 10-Q 14 Feb 2018 2018 Q3
Q3 2017 4,323,831 +117,811 +2.8% 30 Sep 2017 10-Q 14 Nov 2017 2018 Q2
Q2 2017 4,307,062 +106,306 +2.5% 30 Jun 2017 10-Q 08 Aug 2017 2018 Q1
Q1 2017 4,289,322 +92,449 +2.2% 31 Mar 2017 10-K 26 Jun 2018 2018 FY
Q4 2016 4,257,754 -13,084,283 -75% 31 Dec 2016 10-Q 17 Feb 2017 2017 Q3
Q3 2016 4,206,020 -12,209,745 -74% 30 Sep 2016 10-Q 15 Nov 2016 2017 Q2
Q2 2016 4,200,756 -11,480,809 -73% 30 Jun 2016 10-Q 09 Aug 2016 2017 Q1
Q1 2016 4,196,873 -10,848,207 -72% 31 Mar 2016 10-K 28 Jun 2017 2017 FY
Q4 2015 17,342,037 +8,681,457 +100% 31 Dec 2015 10-Q 16 Feb 2016 2016 Q3
Q3 2015 16,415,765 +7,830,383 +91% 30 Sep 2015 10-Q 10 Nov 2015 2016 Q2
Q2 2015 15,681,565 +7,221,420 +85% 30 Jun 2015 10-Q 07 Aug 2015 2016 Q1
Q1 2015 15,045,080 +6,884,935 +84% 31 Mar 2015 10-K 21 Jun 2016 2016 FY
Q4 2014 8,660,580 +1,421,449 +20% 31 Dec 2014 10-Q 12 Feb 2015 2015 Q3
Q3 2014 8,585,382 +1,951,688 +29% 30 Sep 2014 10-Q 13 Nov 2014 2015 Q2
Q2 2014 8,460,145 +1,834,590 +28% 30 Jun 2014 10-Q 12 Aug 2014 2015 Q1
Q1 2014 8,160,145 +1,576,995 +24% 31 Mar 2014 10-K 16 Jun 2015 2015 FY
Q4 2013 7,239,131 -30,100,757 -81% 31 Dec 2013 10-Q 14 Feb 2014 2013 Q3
Q3 2013 6,633,694 -26,135,209 -80% 30 Sep 2013 10-Q 19 Nov 2013 2013 Q2
Q2 2013 6,625,555 -25,928,107 -80% 30 Jun 2013 10-Q 14 Aug 2013 2013 Q1
Q1 2013 6,583,150 +2,438,944 +59% 31 Mar 2013 10-K 30 Jun 2014 2014 FY
Q4 2012 37,339,888 +8,484,159 +29% 31 Dec 2012 10-Q 13 Feb 2013 2012 Q3
Q3 2012 32,768,903 +5,911,703 +22% 30 Sep 2012 10-Q 08 Nov 2012 2012 Q2
Q2 2012 32,553,662 +5,803,234 +22% 30 Jun 2012 10-Q/A 31 Aug 2012 2012 Q1
Q1 2012 4,144,206 -22,432,096 -84% 31 Mar 2012 10-K 25 Jun 2013 2012 FY
Q4 2011 28,855,729 31 Dec 2011 10-Q 10 Feb 2012 2011 Q3
Q3 2011 26,857,200 30 Sep 2011 10-Q 03 Nov 2011 2011 Q2
Q2 2011 26,750,428 30 Jun 2011 10-Q/A 09 Aug 2011 2011 Q1
Q1 2011 26,576,302 31 Mar 2011 10-K 21 Jun 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.